(Reuters) – UnitedHealth Group said on Friday it will focus on finding a way to make GLP-1 drugs, used for the treatment of weight loss and diabetes, more affordable for its customers.
(Reporting by Mariam Sunny in Bengaluru; Editing by Sherry Jacob-Phillips)
